---
title: "Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference | DERM Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286965311.md"
description: "Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference | DERM Stock News"
datetime: "2026-05-19T12:45:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286965311.md)
  - [en](https://longbridge.com/en/news/286965311.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286965311.md)
---

# Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference | DERM Stock News

Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference | DERM Stock News

### Related Stocks

- [DERM.US](https://longbridge.com/en/quote/DERM.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Lynozyfic® shows quick, significant responses in all second-line-plus systemic AL amyloidosis patients.](https://longbridge.com/en/news/287274655.md)
- [Vertex Says Health Canada Accepts Suzetrigine Application for Review](https://longbridge.com/en/news/287257602.md)
- [Nuvalent to present pivotal ALKOVE-1 neladalkib data in ALK-positive NSCLC at ASCO 2026](https://longbridge.com/en/news/287275055.md)
- [Black Diamond reports Phase 2 silevertinib mPFS 15.2 months in frontline EGFR-mutant NSCLC](https://longbridge.com/en/news/287274011.md)
- [Cardiff Oncology updates Phase 2 onvansertib data in first-line RAS-mutated mCRC trial](https://longbridge.com/en/news/287272648.md)